Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Strides Pharma Science Ltd
Press Release Jul 04 2023
Business
Jul 5 2023
4 min read

Press Release Jul 04 2023

Strides Pharma Science Limited has informed the Exchange regarding a press release dated July 04, 2023, titled "Stelis Biopharma enters into a binding term sheet with Syngene International Limited to divest its Unit 3 multi-modal facility for a gross consideration of INR 7,020 million".

View Attachment